KPRX Kiora Pharmaceuticals, Inc.
Healthcare$2.56-4.48%ClosedMarket Cap: $11.3M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.77
P/S
0.00
EV/EBITDA
-0.06
DCF Value
$2.55
FCF Yield
-92.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-59.3%
ROA
-52.1%
ROIC
-62.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-2.5M | $-2.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-7.3M | $-6.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-9.5M | $-10.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-794.4K | $26.8K | $— | — |
| Q2 null | $0.00 | NaN% | $-2.4M | $-2.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.3M | $-2.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-2.6M | $-4.2M | $— | — |
| FY null | $16.0M | 100.0% | $4.5M | $3.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.6M | $-3.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.5M | $-2.2M | $— | — |
| Q1 null | $16.0M | 100.0% | $13.2M | $13.5M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-2.0M | $-2.3M | $-0.29 | — |